Contact Us
Drug Search Results
More Filters [+]

Metomidate

Alternative Names: metomidate
Latest Update: 2024-03-15
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: GABA Modulator

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Organisation name was not entered
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Metomidate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Hyperaldosteronism

Phase 3: Hyperaldosteronism|Adenoma|Hypertension, Renal

Phase 2: Hepatocellular Carcinoma

Phase 1: Hyperaldosteronism|Adenoma|Hypertension

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
PA_MTO

P3

Recruiting

Hypertension, Renal|Hyperaldosteronism|Adenoma

2024-12-31

PA_CURE

P1

Completed

Hypertension|Hyperaldosteronism|Adenoma

2021-03-30

MIA

N/A

Completed

Hyperaldosteronism

2015-08-01

2008-000051-10

P4

Terminated

Hyperaldosteronism

2011-05-23

Recent News Events

Date

Type

Title

03/15/2024

PubMed

 The Promise of Nuclear Imaging as an Alternative to Adrenal Venous Sampling for the Detection of Aldosterone-producing Adenomas.

01/19/2024

PubMed

 Detection and quantification of etomidate and metomidate in human hairs by ultraperformance liquid chromatography with triple quadrupole mass spectrometry (UPLC-MS/MS).

01/11/2024

PubMed

 What We Know about and What Is New in Primary Aldosteronism.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions